Angina reduction after BRSs implantation: Correlation with changes in coronary hemodynamics

Nick E.J. West; Adam John Dunbar Brown; Stephen P. Hoole

doi:10.1201/9781315380629

Angina reduction after BRSs implantation: Correlation with changes in coronary hemodynamics

Nick E.J. West, Adam John Dunbar Brown, Stephen P. Hoole

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

1 Citation (Scopus)

Abstract

Despite huge advances in interventional cardiology, as a specialty we remain rooted in the immediate: most novel devices are assessed at short-term time points with low-frequency clinical endpoints that have to be combined into composites in order to provide a reasonable chance of demonstrating either noninferiority or superiority [1,2]. As far as longer-term patient prognosis goes, percutaneous coronary intervention (PCI) provides at best a modest impact, with benefits largely confined to patients with substantial ischemic burden [3] or acute ST-elevation myocardial infarction [4].

Original language	English
Title of host publication	Bioresorbable Scaffolds
Subtitle of host publication	From Basic Concept to Clinical Applications
Editors	Yoshinobu Onuma, Patrick W.J.C. Serruys
Place of Publication	Boca Raton
Publisher	CRC Press
Pages	215-223
Number of pages	9
ISBN (Electronic)	9781498779777
ISBN (Print)	9781498779746
DOIs	https://doi.org/10.1201/9781315380629
Publication status	Published - 1 Jan 2017
Externally published	Yes

Access to Document

10.1201/9781315380629

Link to publication in Scopus

Cite this

@inbook{6bd83083f0c04835818205c53603b26b,

title = "Angina reduction after BRSs implantation: Correlation with changes in coronary hemodynamics",

abstract = "Despite huge advances in interventional cardiology, as a specialty we remain rooted in the immediate: most novel devices are assessed at short-term time points with low-frequency clinical endpoints that have to be combined into composites in order to provide a reasonable chance of demonstrating either noninferiority or superiority [1,2]. As far as longer-term patient prognosis goes, percutaneous coronary intervention (PCI) provides at best a modest impact, with benefits largely confined to patients with substantial ischemic burden [3] or acute ST-elevation myocardial infarction [4].",

author = "West, {Nick E.J.} and Brown, {Adam John Dunbar} and Hoole, {Stephen P.}",

year = "2017",

month = jan,

day = "1",

doi = "10.1201/9781315380629",

language = "English",

isbn = "9781498779746",

pages = "215--223",

editor = "Onuma, {Yoshinobu } and Serruys, {Patrick W.J.C. }",

booktitle = "Bioresorbable Scaffolds",

publisher = "CRC Press",

address = "Australia",

}

Angina reduction after BRSs implantation : Correlation with changes in coronary hemodynamics. / West, Nick E.J.; Brown, Adam John Dunbar; Hoole, Stephen P.

Bioresorbable Scaffolds: From Basic Concept to Clinical Applications. ed. / Yoshinobu Onuma; Patrick W.J.C. Serruys. Boca Raton : CRC Press, 2017. p. 215-223.

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

TY - CHAP

T1 - Angina reduction after BRSs implantation

T2 - Correlation with changes in coronary hemodynamics

AU - West, Nick E.J.

AU - Brown, Adam John Dunbar

AU - Hoole, Stephen P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Despite huge advances in interventional cardiology, as a specialty we remain rooted in the immediate: most novel devices are assessed at short-term time points with low-frequency clinical endpoints that have to be combined into composites in order to provide a reasonable chance of demonstrating either noninferiority or superiority [1,2]. As far as longer-term patient prognosis goes, percutaneous coronary intervention (PCI) provides at best a modest impact, with benefits largely confined to patients with substantial ischemic burden [3] or acute ST-elevation myocardial infarction [4].

AB - Despite huge advances in interventional cardiology, as a specialty we remain rooted in the immediate: most novel devices are assessed at short-term time points with low-frequency clinical endpoints that have to be combined into composites in order to provide a reasonable chance of demonstrating either noninferiority or superiority [1,2]. As far as longer-term patient prognosis goes, percutaneous coronary intervention (PCI) provides at best a modest impact, with benefits largely confined to patients with substantial ischemic burden [3] or acute ST-elevation myocardial infarction [4].

UR - http://www.scopus.com/inward/record.url?scp=85055379384&partnerID=8YFLogxK

U2 - 10.1201/9781315380629

DO - 10.1201/9781315380629

M3 - Chapter (Book)

AN - SCOPUS:85055379384

SN - 9781498779746

SP - 215

EP - 223

BT - Bioresorbable Scaffolds

A2 - Onuma, Yoshinobu

A2 - Serruys, Patrick W.J.C.

PB - CRC Press

CY - Boca Raton

ER -